TY - JOUR
T1 - Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
AU - Weiss, Scott L.
AU - Peters, Mark J.
AU - Alhazzani, Waleed
AU - Agus, Michael S.D.
AU - Flori, Heidi R.
AU - Inwald, David P.
AU - Nadel, Simon
AU - Schlapbach, Luregn J.
AU - Tasker, Robert C.
AU - Argent, Andrew C.
AU - Brierley, Joe
AU - Carcillo, Joseph
AU - Carrol, Enitan D.
AU - Carroll, Christopher L.
AU - Cheifetz, Ira M.
AU - Choong, Karen
AU - Cies, Jeffry J.
AU - Cruz, Andrea T.
AU - De Luca, Daniele
AU - Deep, Akash
AU - Faust, Saul N.
AU - De Oliveira, Claudio Flauzino
AU - Hall, Mark W.
AU - Ishimine, Paul
AU - Javouhey, Etienne
AU - Joosten, Koen F.M.
AU - Joshi, Poonam
AU - Karam, Oliver
AU - Kneyber, Martin C.J.
AU - Lemson, Joris
AU - MacLaren, Graeme
AU - Mehta, Nilesh M.
AU - Møller, Morten Hylander
AU - Newth, Christopher J.L.
AU - Nguyen, Trung C.
AU - Nishisaki, Akira
AU - Nunnally, Mark E.
AU - Parker, Margaret M.
AU - Paul, Raina M.
AU - Randolph, Adrienne G.
AU - Ranjit, Suchitra
AU - Romer, Lewis H.
AU - Scott, Halden F.
AU - Tume, Lyvonne N.
AU - Verger, Judy T.
AU - Williams, Eric A.
AU - Wolf, Joshua
AU - Wong, Hector R.
AU - Zimmerman, Jerry J.
AU - Kissoon, Niranjan
AU - Tissieres, Pierre
N1 - Funding Information:
These guidelines were solely funded by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine.
Funding Information:
The following sponsoring organizations with formal liaison appointees endorse this guideline: American Academy of Pediatrics; Australia and New Zealand Intensive Care Society; Canadian Critical Care Society; European Society of Intensive Care Medicine; European Society of Paediatric and Neonatal Intensive Care; Pediatric Infectious Disease Society; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Society of Critical Care Medicine; UK Sepsis Trust; World Federation of Pediatric Intensive and Critical Care Societies. These guidelines were solely funded by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine.
Funding Information:
We wish to thank Darlene Barkman, MA, and Janna Pogers, PT, MPT, NCS, CSRS for their sensitive and insightful comments from the perspective of parents of children with sepsis. Their input, particularly related to ranking the importance of outcomes to consider through the literature search, provided valuable direction to the panel. We also wish to thank Rebecca Skidmore and James D. Medd for their dedication as they conducted the literature searches for the five panels. Their experience and professionalism contributed greatly to the final publication. Finally, appreciation is extended to Deborah L. McBride for project management and editorial support. The following sponsoring organizations with formal liaison appointees endorse this guideline: American Academy of Pediatrics; Australia and New Zealand Intensive Care Society; Canadian Critical Care Society; European Society of Intensive Care Medicine; European Society of Paediatric and Neonatal Intensive Care; Pediatric Infectious Disease Society; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Society of Critical Care Medicine; UK Sepsis Trust; World Federation of Pediatric Intensive and Critical Care Societies. These guidelines were solely funded by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine.
Publisher Copyright:
© 2020, ESICM, SCCM and WFPICCS 2020.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Objectives: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. Design: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. Methods: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, “in our practice” statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. Results: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no recommendations could be made; but, for 10 of these, “in our practice” statements were provided. In addition, 52 research priorities were identified. Conclusions: A large cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations. Despite this challenge, these recommendations regarding the management of children with septic shock and other sepsis-associated organ dysfunction provide a foundation for consistent care to improve outcomes and inform future research.
AB - Objectives: To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. Design: A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. Methods: The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, “in our practice” statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. Results: The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 49 were weak recommendations, and nine were best-practice statements. For 13 questions, no recommendations could be made; but, for 10 of these, “in our practice” statements were provided. In addition, 52 research priorities were identified. Conclusions: A large cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations. Despite this challenge, these recommendations regarding the management of children with septic shock and other sepsis-associated organ dysfunction provide a foundation for consistent care to improve outcomes and inform future research.
KW - Evidence-based medicine
KW - Grading of Recommendations Assessment, Development and Evaluation criteria
KW - Guidelines
KW - Infection
KW - Pediatrics
KW - Sepsis
KW - Septic shock
KW - Surviving Sepsis Campaign
UR - http://www.scopus.com/inward/record.url?scp=85079082160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079082160&partnerID=8YFLogxK
U2 - 10.1007/s00134-019-05878-6
DO - 10.1007/s00134-019-05878-6
M3 - Article
C2 - 32030529
AN - SCOPUS:85079082160
SN - 0342-4642
VL - 46
SP - 10
EP - 67
JO - Intensive Care Medicine
JF - Intensive Care Medicine
ER -